Adelaide Research & Scholarship: Search

Search

Results 31-40 of 42 (Search time: 0.008 seconds).

previous
1
2
3
4
5
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2007	Control of androgen receptor signaling in prostate cancer by the cochaperone small glutamine-rich tetratricopeptide repeat containing protein α	Buchanan, G.; Ricciardelli, C.; Harris, J.; Prescott, J.; Yu, Z.; Jia, L.; Butler, L.; Marshall, V.; Scher, H.; Gerald, W.; Coetzee, G.; Tilley, W.
	2007	Suberoylanilide hydroxamic acid (vorinostat) represses androgen receptor expression and acts synergistically with an androgen receptor antagonist to inhibit prostate cancer cell proliferation	Marrocco, D.; Tilley, W.; Bianco-Miotto, T.; Evdokiou, A.; Scher, H.; Rifkind, R.; Marks, P.; Richon, V.; Butler, L.
	2012	Evidence for efficacy of new Hsp90 inhibitors revealed by ex vivo culture of human prostate tumors	Centenera, M.; Gillis, J.; Hanson, A.; Jindal, S.; Taylor, R.; Risbridger, G.; Sutherland, P.; Scher, H.; Raj, G.; Knudsen, K.; Yeadon, T.; Tilley, W.; Butler, L.
	2006	Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA	Severi, G.; Hayes, V.; Neufing, P.; Padilla, E.; Tilley, W.; Eggleton, S.; Morris, H.; English, D.; Southey, M.; Hopper, J.; Sutherland, R.; Boyle, P.; Giles, G.
	2007	The 3rd Pacific Rim meeting on breast and prostate cancer: Progress in hormonal carcinogenesis and the enduring influence of Ron Ross	Reichardt, J.; Tilley, W.
	2011	GSTP1 DNA methylation and expression status is indicative of 5-aza-2'-deoxycytidine efficacy in human prostate cancer cells	Chiam, K.; Centenera, M.; Butler, L.; Tilley, W.; Bianco-Miotto, T.; Agoulnik, I.
	2002	A novel androgen receptor mutant, A748T, exhibits hormone concentration-dependent defects in nuclear accumulation and activity despite normal hormone-binding affinity	James, A.; Agoulnik, I.; Harris, J.; Buchanan, G.; Tilley, W.; Marcelli, M.; Lamb, D.; Weigel, N.
	2012	Circulating microRNAs: macro-utility as markers of prostate cancer?	Selth, L.; Tilley, W.; Butler, L.
	2004	Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer	Scher, H.; Buchanan, G.; Gerald, W.; Butler, L.; Tilley, W.
	2010	Co-expression of the androgen receptor and the transcription factor ZNF652 is related to prostate cancer outcome	Callen, D.; Ricciardelli, C.; Butler, M.; Stapleton, A.; Stahl, J.; Kench, J.; Horsfall, D.; Tilley, W.; Schulz, R.; Nesland, J.; Neilsen, P.; Kumar, R.; Holm, R.